Tsochatzis EA - Search Results

1

Advancing the global public health agenda for NAFLD: a consensus statement.

Lazarus JV, Mark HE, Anstee QM, Arab JP, Batterham RL, Castera L, Cortez-Pinto H, Crespo J, Cusi K, Dirac MA, Francque S, George J, Hagström H, Huang TT, Ismail MH, Kautz A, Sarin SK, Loomba R, Miller V, Newsome PN, Ninburg M, Ocama P, Ratziu V, Rinella M, Romero D, Romero-Gómez M, Schattenberg JM, Tsochatzis EA, Valenti L, Wong VW, Yilmaz Y, Younossi ZM, Zelber-Sagi S; NAFLD Consensus Consortium. Lazarus JV, et al. Among authors: tsochatzis ea. Nat Rev Gastroenterol Hepatol. 2022 Jan;19(1):60-78. doi: 10.1038/s41575-021-00523-4. Epub 2021 Oct 27. Nat Rev Gastroenterol Hepatol. 2022. PMID: 34707258 Free article. Review.

2

Hepatobiliary and pancreatic: spontaneous splenorenal shunts in portal hypertension.

Tsochatzis E, Venerito M, Papatheodoridis GV, Archimandritis AJ, Mönkemüller K, Malfertheiner P, Rickes S. Tsochatzis E, et al. J Gastroenterol Hepatol. 2006 Jul;21(7):1214. doi: 10.1111/j.1440-1746.2006.04555.x. J Gastroenterol Hepatol. 2006. PMID: 16824079 No abstract available.

3

The evolving role of leptin and adiponectin in chronic liver diseases.

Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. Tsochatzis E, et al. Am J Gastroenterol. 2006 Nov;101(11):2629-40. doi: 10.1111/j.1572-0241.2006.00848.x. Epub 2006 Sep 4. Am J Gastroenterol. 2006. PMID: 16952281 Review.

4

Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.

Tsochatzis E, Papatheodoridis GV, Manesis EK, Kafiri G, Tiniakos DG, Archimandritis AJ. Tsochatzis E, et al. Aliment Pharmacol Ther. 2008 Jan 1;27(1):80-9. doi: 10.1111/j.1365-2036.2007.03538.x. Epub 2007 Oct 5. Aliment Pharmacol Ther. 2008. PMID: 17919273 Free article.

5

Adipokines and insulin resistance in chronic hepatitis C.

Tsochatzis E, Papatheodoridis GV, Archimandritis AJ. Tsochatzis E, et al. Hepatology. 2007 Dec;46(6):2050-1; author reply 2051. doi: 10.1002/hep.22005. Hepatology. 2007. PMID: 18046709 No abstract available.

6

Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.

Tsochatzis E, Papatheodoridis GV, Hadziyannis E, Georgiou A, Kafiri G, Tiniakos DG, Manesis EK, Archimandritis AJ. Tsochatzis E, et al. Scand J Gastroenterol. 2008;43(9):1128-36. doi: 10.1080/00365520802085387. Scand J Gastroenterol. 2008. PMID: 18609175

7

Insulin resistance and metabolic syndrome in chronic liver diseases: old entities with new implications.

Tsochatzis EA, Manolakopoulos S, Papatheodoridis GV, Archimandritis AJ. Tsochatzis EA, et al. Scand J Gastroenterol. 2009;44(1):6-14. doi: 10.1080/00365520802273058. Scand J Gastroenterol. 2009. PMID: 18661429 Review.

8

Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B.

Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ. Tsochatzis E, et al. Scand J Gastroenterol. 2009;44(6):752-9. doi: 10.1080/00365520902803515. Scand J Gastroenterol. 2009. PMID: 19296398

9

Adipokines in nonalcoholic steatohepatitis: from pathogenesis to implications in diagnosis and therapy.

Tsochatzis EA, Papatheodoridis GV, Archimandritis AJ. Tsochatzis EA, et al. Mediators Inflamm. 2009;2009:831670. doi: 10.1155/2009/831670. Epub 2009 Jun 3. Mediators Inflamm. 2009. PMID: 19753129 Free PMC article. Review.

10

Smoking is associated with histological severity in nonalcoholic steatohepatitis.

Tsochatzis EA, Papatheodoridis GV. Tsochatzis EA, et al. Hepatology. 2010 Oct;52(4):1522-3. doi: 10.1002/hep.23751. Hepatology. 2010. PMID: 20814892 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

283 results

Search Page